SMALL CELL CARCINOMA
Clinical trials for SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy drug shows promise for rare and Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called pembrolizumab (Keytruda) in 157 people with rare cancers that have spread or cannot be removed. The drug helps the immune system fight cancer by blocking a protein that tumors use to hide. The main goal is to see if the drug can stop the cancer from…
Matched conditions: SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
Promising combo cancer trial pulled before it began
Disease control TerminatedThis study planned to test two drugs, tarlatamab and sacituzumab govitecan, in people with advanced small cell lung cancer or a similar neuroendocrine cancer that had not responded to prior treatment. The goal was to see if the combination was safe and could shrink tumors. Howeve…
Matched conditions: SMALL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC